Outsourcing on the rise, despite supply chain risks; Lonza upbeat;

> Contract manufacturer Lonza says business is good--so good that it confirms "an intact trend toward outsourcing." Article

> Pharmaceutical outsourcing is creating a risky supply chain environment. Story

> Next week, ISPE will release GAMP Good Practice Guide: Calibration Management, Second Edition. ISPE release

> Acsis, Cognex, Nosco and Omega Design have teamed to help drugmakers wrestling with upcoming federal and state ePedigree and serialization mandates. Release

> Good to know: Chief legal officers at pharma manufacturing companies boasted the highest median salary last year--$355,000--among all industries. Article

> Layoffs in the pharmaceutical industry dropped to 1,900 in October, way down from September's 6,069. Item

> Hard times await drug counterfeiters in Nigeria with the reactivation of the federal task force on counterfeit and fake drugs. News

> Vietnamese doctors and patients alike prefer imported drugs over cheaper domestic ones. Report

> Use a risk-based approach in selecting API manufacturers and suppliers; conduct audits. Article

> Potentially toxic belladonna in some Hyland's Teething Tablets has led to a recall. FDA update

> Joyce Chiu, a 20-year veteran of the chemical and life sciences industries, has earned  the ISPE Certified Pharmaceutical Industry Professional credential. ISPE release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.